Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Planned sale 10% owner sold 189,431 shares at an average $6.41 ($1,213,667)
  2. 4 Planned sale 10% owner sold 463,774 shares at an average $6.27 ($2,906,278)
  3. 4 Planned sale EVP & Chief Financial Officer sold 6,799 shares at $5.56 ($37,782)
  4. 4 Planned sale EVP, General Counsel, Corp Sec sold 2,385 shares at $5.16 ($12,307)
  5. 4 Planned sale EVP and General Counsel sold 1,365 shares at $5.86 ($8,003)
  6. 4 Planned sale Director sold 22,000 shares at $5.64 ($124,047)
  7. 4 Planned sale 10% owner sold 24,553 shares at an average $6.50 ($159,655)
  8. 4 Planned sale 10% owner sold 113,099 shares at an average $6.01 ($679,870)
  9. 4 Planned sale 10% owner sold 298,649 shares at an average $6.07 ($1,812,378)
  10. 4 Planned sale 10% owner sold 330,210 shares at an average $6.23 ($2,058,247)
  11. 4 Planned sale 10% owner sold 29,515 shares at an average $6.08 ($179,563)
  12. 4 Planned sale 10% owner sold 251,360 shares at an average $6.14 ($1,543,899)
  13. 4 Planned sale 10% owner sold 538,375 shares at an average $5.99 ($3,223,939)
  14. 4 Planned sale 10% owner sold 524,297 shares at an average $5.57 ($2,922,426)
  15. 4 Planned sale Director sold 22,000 shares at $5.84 ($128,396)
  16. 4 Planned sale Director sold 22,000 shares at $4.99 ($109,811)
  17. 4 Planned sale Director sold 22,000 shares at $4.99 ($109,699)
  18. 4 Planned sale EVP and Chief Medical Officer sold 10,382 shares at an average $5.47 ($56,791)
  19. 4 Planned sale Director sold 22,000 shares at $5.10 ($112,207)
  20. 4 Other disposition Director disposed of 14,027 shares (other)

Page 3 of 25 · 491 filings